TSC2 and breast cancer: Furthermore, the abundance of ARD1 and TSC2 exhibited a significant correlation across various tumor types, particularly in breast cancer, where ARD1 levels notably influenced TSC2 stability and inhibition of the mTOR signaling pathway [41].